A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : RV / resveratrol

[Related PubMed/MEDLINE]
Total Number of Papers: 130
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   RV  (>> Co-occurring Abbreviation)
Long Form:   resveratrol
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Acute resveratrol supplementation in coronary artery disease: towards patient stratification. CABG, CAD, FMD, PCI
2020 Combined cardio-protective ability of syringic acid and resveratrol against isoproterenol induced cardio-toxicity in rats via attenuating NF-kB and TNF-alpha pathways. CK-MB, COMB, ISO, LDH, NF-kB, SA, TEM, TNF-alpha
2020 Enhancement of the cancer inhibitory effect of the bioactive food component resveratrol by nanoparticle based delivery. NRV, TPA
2020 Formulation and evaluation of resveratrol loaded cubosomal nanoformulation for topical delivery. RC, RC-Gel, RC-Gel
2020 Investigation of molecular mechanisms of experimental compounds in murine models of chronic allergic airways disease using synchrotron Fourier-transform infrared microspectroscopy. FPA, LSF, OVA, RLN, S-FTIR, TSA, VPA
2020 Modulation of non-coding RNAs by resveratrol in ovarian cancer cells: In silico analysis and literature review of the anti-cancer pathways involved. GO, lncRNAs, miRNAs
2020 Molecular modelling of the antiviral action of Resveratrol derivatives against the activity of two novel SARS CoV-2 and 2019-nCoV receptors. ---
2020 Resveratrol bidirectionally regulates insulin effects in skeletal muscle through alternation of intracellular redox homeostasis. ROS
2020 Resveratrol suppresses melanoma growth by promoting autophagy through inhibiting the PI3K/AKT/mTOR signaling pathway. LC3
10  2019 A pH-Induced Reversible Assembly System with Resveratrol-Controllable Loading and Release for Enhanced Tumor-Targeting Chemotherapy. Ft, PIRAS
11  2019 Atorvastatin and Conditioned Media from Atorvastatin-Treated Human Hematopoietic Stem/Progenitor-Derived Cells Show Proangiogenic Activity In Vitro but Not In Vivo. ASA, AT, HAoECs, HMOX1, HSPCs, MAC, MET, PACs, PBMCs, SR
12  2019 Effects of resveratrol and genistein on growth, nutrient utilization and fatty acid composition of rainbow trout. DM, FA
13  2019 Endothelial Cells Deconjugate Resveratrol Metabolites to Free Resveratrol: A Possible Role in Tissue Factor Modulation. HAECs, RVmet, TF, TNF-alpha
14  2019 Evolvement of nutraceutical onion plants engineered for resveratrol biosynthetic pathway. ---
15  2019 Intracellular Delivery of Natural Antioxidants via Hyaluronan Nanohydrogels. AX, CU, HA, NHs, ROS
16  2019 Metabolic profile and structure-activity relationship of resveratrol and its analogs in human bladder cancer cells. ARV, ORV, PD
17  2019 Mitochondria-Targeted and Resveratrol-Loaded Dual-Function Titanium Disulfide Nanosheets for Photothermal-Triggered Tumor Chemotherapy. IR780, NIR
18  2019 Molecular docking analysis of imine stilbene analogs and evaluation of their anti-aging activity using yeast and mammalian cell models. CRS, IMS
19  2019 Protective effects of syringic acid, resveratrol and their combination against isoprenaline administered cardiotoxicity in wistar rats. ALT, AST, CK, COMB, GA, GGT, GPx, GST, hs-CRP, ISO, MI, SA, TPC
20  2019 Resveratrol prevents the development of high blood pressure in spontaneously hypertensive rats through the inhibition of enhanced expression of Gialpha proteins 1. BP, SHRs
21  2019 Resveratrol-delivery vehicle with anti-VEGF activity carried to human retinal pigmented epithelial cells exposed to high-glucose induced conditions. Rh6G, VEGF
22  2019 Role of Resveratrol and Selenium on Oxidative Stress and Expression of Antioxidant and Anti-Aging Genes in Immortalized Lymphocytes from Alzheimer's Disease Patients. AD, HCs, LCLs, ROS, Se
23  2019 Tetramethoxystilbene-Loaded Liposomes Restore Reactive-Oxygen-Species-Mediated Attenuation of Dilator Responses in Rat Aortic Vessels Ex vivo. TMS
24  2018 Beneficial Effects of Resveratrol Administration-Focus on Potential Biochemical Mechanisms in Cardiovascular Conditions. BDNF, ROS
25  2018 Fatty Acid Composition and Fatty Acid Associated Gene-Expression in Gilthead Sea Bream (Sparus aurata) are Affected by Low-Fish Oil Diets, Dietary Resveratrol, and Holding Temperature. DHA, DM, EPA
26  2018 Health Effects of Resveratrol: Results from Human Intervention Trials. T2D
27  2018 PKA-GSK3beta and beta-Catenin Signaling Play a Critical Role in Trans-Resveratrol Mediated Neuronal Differentiation in Human Cord Blood Stem Cells. hCB-MSCs
28  2018 Preparation, characterization, and cellular uptake of resveratrol-loaded trimethyl chitosan nanoparticles. EE, TMC, TP-NPs, TPP
29  2018 Resveratrol alleviates motor and cognitive deficits and neuropathology in the A53T alpha-synuclein mouse model of Parkinson's disease. PD
30  2018 Resveratrol in Patients with Minimal Hepatic Encephalopathy. BDI, HRQL, MHE, QOL, STAI
31  2018 Resveratrol Prevents the Cellular Damages Induced by Monocrotophos via PI3K Signaling Pathway in Human Cord Blood Mesenchymal Stem Cells. hUCB-MSC, MCP
32  2018 Resveratrol protects against sodium nitroprusside induced nucleus pulposus cell apoptosis by scavenging ROS. IVD, NAC, NO, NP, PI, PTIO, ROS, SNP
33  2018 The in vitro radiosensitizer potential of resveratrol on MCF-7 breast cancer cells. BC, IR
34  2017 Differential sensitivities of bladder cancer cell lines to resveratol are unrelated to its metabolic profile. HBC, RVS
35  2017 Fatty Acid Profile Is Modulated by Dietary Resveratrol in Rainbow Trout (Oncorhynchus mykiss). ---
36  2017 Human skin gene expression: Natural (trans) resveratrol versus five resveratrol analogs for dermal applications. IL1A
37  2017 Metabolic Stress Induces Cognitive Disturbances and Inflammation in Aged Mice: Protective Role of Resveratrol. HF, OS
38  2017 Resveratrol prevents angiotensin II-induced hypertrophy of vascular smooth muscle cells through the transactivation of growth factor receptors. Ang II, VSMC
39  2017 Resveratrol-Loaded Albumin Nanoparticles with Prolonged Blood Circulation and Improved Biocompatibility for Highly Effective Targeted Pancreatic Tumor Therapy. CCK-8, HP-RGD NPs, HSA, PEG
40  2017 Synthesis of Novel Imine Stilbene Analogs Exhibiting Potent Anticancer Activity. DMOG
41  2017 The protein restriction mimetic Resveratrol is an autophagy inducer stronger than amino acid starvation in ovarian cancer cells. ---
42  2016 A novel monolithic controlled delivery system of resveratrol for enhanced hepatoprotection: nanoformulation development, pharmacokinetics and pharmacodynamics. RV-SLNs, SGOT, SGPT
43  2016 Differential responses of Trans-Resveratrol on proliferation of neural progenitor cells and aged rat hippocampal neurogenesis. ERKs, NPCs
44  2016 Neuroprotection by combination of resveratrol and enriched environment against ischemic brain injury in rats. EE, MCAO
45  2016 Potentiating the Heat Inactivation of Escherichia coli O157:H7 in Ground Beef Patties by Natural Antimicrobials. CH, RT, SEM
46  2016 Resveratrol alleviates MPTP-induced motor impairments and pathological changes by autophagic degradation of alpha-synuclein via SIRT1-deacetylated LC3. LC3, MPTP, PD, SIRT1
47  2016 Resveratrol attenuates neuronal autophagy and inflammatory injury by inhibiting the TLR4/NF-kappaB signaling pathway in experimental traumatic brain injury. CCI, IL, LC3, NeuN, NF-kappaB, TBI, TLR4, TNF
48  2016 Resveratrol cross-linked chitosan loaded with phospholipid for controlled release and antioxidant activity. DLS, FESEM, FTIR, RVC-lipid, TEM, XRD
49  2016 Resveratrol exerts protective effects on anoxia/reoxygenation injury in cardiomyocytes via miR-34a/Sirt1 signaling pathway. ARI, ROS
50  2016 Resveratrol Pretreatment Protected against Cerebral Ischemia/Reperfusion Injury in Rats via Expansion of T Regulatory Cells. I/R, IL-10
51  2016 Resveratrol promotes differentiation of mouse embryonic stem cells to cardiomyocytes. EBs, ESCs, mESCs
52  2016 Resveratrol Protects Sepsis-Induced Oxidative DNA Damage in Liver and Kidney of Rats. GPx, i.p, MDA, SOD, TNF-alpha
53  2016 Synthesis and skin gene analysis of 4'-acetoxy-resveratrol (4AR), therapeutic potential for dermal applications. 4AR, PCNA
54  2015 Chemopreventive effect of resveratrol and apocynin on pancreatic carcinogenesis via modulation of nuclear phosphorylated GSK3beta and ERK1/2. AC
55  2015 Cross effects of resveratrol and mesenchymal stem cells on liver regeneration and homing in partially hepatectomized rats. HGF, IL-6, MSCs, PCNA, PH, TNF-alpha
56  2015 Dysregulated Ca2+ homeostasis in Fanconi anemia cells. FA, NAC
57  2015 In vitro antiviral effects and 3D QSAR study of resveratrol derivatives as potent inhibitors of influenza H1N1 neuraminidase. 3D-QSAR, CPE, NA
58  2015 In vitro protective effects of resveratrol against oxidative damage in human erythrocytes. DM, DMPC, DMPE
59  2015 Inhibition of metalloproteinase activity in FANCA is linked to altered oxygen metabolism. BM, FA, FANCA, MMP, MPs, NAC
60  2015 omega-3 PUFAs and Resveratrol Differently Modulate Acute and Chronic Inflammatory Processes. DHA, EPA, PBLs
61  2015 Resveratrol Ameliorates Clonidine-Induced Endothelium-Dependent Relaxation Involving Akt and Endothelial Nitric Oxide Synthase Regulation in Type 2 Diabetic Mice. ACh, eNOS, NO
62  2015 Resveratrol prevents doxorubicin-induced cardiotoxicity in H9c2 cells through the inhibition of endoplasmic reticulum stress and the activation of the Sirt1 pathway. CHOP, DOX, ER, GRP78, NIC
63  2015 Resveratrol relieves gestational diabetes mellitus in mice through activating AMPK. GDM
64  2015 Synergistic Induction of Erlotinib-Mediated Apoptosis by Resveratrol in Human Non-Small-Cell Lung Cancer Cells by Down-Regulating Survivin and Up-Regulating PUMA. EGFR, NSCLC, siRNA
65  2014 Effect of short-term polyphenol treatment on endothelial dysfunction and thromboxane A2 levels in streptozotocin-induced diabetic mice. ACh, CA, i.p, MO, NO, STZ, TXB2
66  2014 Evaluation of resveratrol and N-acetylcysteine for cancer chemoprevention in a Fanconi anemia murine model. FA, NAC
67  2014 Friend or foe? Effect of oral resveratrol on cisplatin ototoxicity. ABR, DPOAEs, TUNEL
68  2014 One-step reduction and PEGylation of graphene oxide for photothermally controlled drug delivery. DeltaPsim, NGO, NIR
69  2014 Pomegranate Juice Enhances Healthy Lifespan in Drosophila melanogaster: An Exploratory Study. PJ
70  2014 Resveratrol and vitamin E rescue valproic acid-induced teratogenicity: the mechanism of action. CEM, HH, VPA
71  2014 Resveratrol based oral nutritional supplement produces long-term beneficial effects on structure and visual function in human patients. AMD, OTC
72  2014 Resveratrol enhances mitomycin C-mediated suppression of human colorectal cancer cell proliferation by up-regulation of p21WAF1/CIP1. MMC
73  2014 Resveratrol metabolic fingerprinting after acute and chronic intakes of a functional beverage in humans. FB, UPLC
74  2014 Resveratrol protects astrocytes against traumatic brain injury through inhibiting apoptotic and autophagic cell death. GSK-3beta, mPTP, ROS, TBI
75  2014 Resveratrol protects chondrocytes from apoptosis via altering the ultrastructural and biomechanical properties: an AFM study. AFM, OA, SNP
76  2014 Resveratrol protects rabbit articular chondrocyte against sodium nitroprusside-induced apoptosis via scavenging ROS. FCM, NO, OA, ROS, SNP
77  2014 Strategies to improve the solubility and stability of stilbene antioxidants: a comparative study between cyclodextrins and bile acids. HP-CDs, PS, PT
78  2014 The cell membrane is the main target of resveratrol as shown by interdisciplinary biomolecular/cellular and biophysical approaches. ---
79  2014 The proteomic and genomic teratogenicity elicited by valproic acid is preventable with resveratrol and alpha-tocopherol. CEM, Vit E, VPA
80  2014 Treatment of FANCA cells with resveratrol and N-acetylcysteine: a comparative study. FA, NAC
81  2013 Highly efficient biotransformation of polydatin to resveratrol by snailase hydrolysis using response surface methodology optimization. RSM
82  2013 Mechanism of resveratrol on the promotion of induced pluripotent stem cells. ESC, iPSCs, MEFs
83  2013 Modulation of bacterial ghosts--induced nitric oxide production in macrophages by bacterial ghost-delivered resveratrol. BGs, NO
84  2013 Observation of human retinal remodeling in octogenarians with a resveratrol based nutritional supplement. AMD, VEGF
85  2013 Protective effects of resveratrol on sepsis-induced DNA damage in the lymphocytes of rats. Fpg
86  2013 Resveratrol enhances ionizing radiation-induced premature senescence in lung cancer cells. DSBs, IR, NSCLC, SA-beta-gal
87  2013 Resveratrol induces premature senescence in lung cancer cells via ROS-mediated DNA damage. DSBs, NAC, NOX5, NSCLC, ROS, SA-beta-gal
88  2012 Differential effects of low-dose resveratrol on adiposity and hepatic steatosis in diet-induced obese mice. FA, HFD
89  2012 Effects of resveratrol on biomarkers of oxidative stress and on the activity of delta aminolevulinic acid dehydratase in liver and kidney of streptozotocin-induced diabetic rats. ALT, AST, CAT, gamma-GT, NPSH, SOD, STZ
90  2012 Plant polyphenols regulate chemokine expression and tissue repair in human keratinocytes through interaction with cytoplasmic and nuclear components of epidermal growth factor receptor system. AP-1, EGFR, ERK, IL-8, IP-10, MCP-1, PD, PPs, QR, T/I, TGF-alpha, VB
91  2012 Resveratrol ameliorates diabetes-related metabolic changes via activation of AMP-activated protein kinase and its downstream targets in db/db mice. AMPK, p-IKK, UCP
92  2012 Resveratrol enhances solar UV-induced responses in normal human epidermal keratinocytes. AhR, FICZ, HEK
93  2012 Resveratrol induces apoptosis via a Bak-mediated intrinsic pathway in human lung adenocarcinoma cells. ---
94  2012 Resveratrol inhibits Epstein Barr Virus lytic cycle in Burkitt's lymphoma cells by affecting multiple molecular targets. EBV, ROS
95  2012 Resveratrol suppresses tumorigenicity and enhances radiosensitivity in primary glioblastoma tumor initiating cells by inhibiting the STAT3 axis. GBM, sh-STAT3, TIC
96  2011 Anti-tumor and immunomodulatory activity of resveratrol in vitro and its potential for combining with cancer immunotherapy. ADCC, IC
97  2011 Modulation of intracellular glutathione affects adipogenesis in 3T3-L1 cells. BSO, GCL, GSHest, MCE
98  2011 Resveratrol blocks Akt activation in angiotensin II- or EGF-stimulated vascular smooth muscle cells in a redox-independent manner. Ang II, EGF, NOX, ROS, VSMCs
99  2011 Resveratrol induces mitochondria-mediated AIF and to a lesser extent caspase-9-dependent apoptosis in human lung adenocarcinoma ASTC-a-1 cells. FCM, FRET, WB
100  2011 Resveratrol inhibits migration and Rac1 activation in EGF- but not PDGF-activated vascular smooth muscle cells. EGF, PDGF, PI3K, VSMC